HIMA (Health Industry Manufacturers Association) warns that FDA could introduce user fees
This article was originally published in Clinica
Executive Summary
The issue of user fees could be surfacing once again in the US. The FDA has published a document in the Federal Register (November 24), which states that a lack of funds may prevent the agency from meeting some of its duties prescribed in the FDA Modernization Act.